Results 41 to 50 of about 8,456 (172)
Diabetes/Metabolism Research and Reviews, Volume 42, Issue 1, January 2026.ABSTRACT Timely diagnosis of type 1 diabetes (T1D), especially in high‐risk populations, is crucial for preventing serious health complications. T1D is a chronic progressive autoimmune disease that has presymptomatic stages that can be identified through the detection of islet autoantibodies. Given that T1D is associated with other autoimmune diseases,
Nick Thomas +8 more
wiley +1 more source
Advances in Public Health, Volume 2026, Issue 1, 2026.Purpose Thyroid eye disease (TED) is the most common orbital disorder in adults. Its initial clinical manifestations are heterogeneous and may influence early diagnosis and management. However, limited data exist on real‐world perspectives from oculoplastic surgeons who frequently manage patients with TED.
Shiqi Hui +4 more
wiley +1 more source
Perspective in pharmacological management of Graves' hyperthyroidism and orbitopathy
, 2008 Drugs currently used for Graves' hyperthyroidism (thionamides) or for the major extrathyroidal expression of Graves' disease, Graves' , orbitopathy (systemic glucocorticoids with or without orbital radiotherapy), have limited effects on the autoimmune ...
Bartalena L., Tanda M. L., Lai A.
core +1 more source
Graves' orbitopathy: Diagnosis and treatment.
, 2018 1. Clinical assessment of Graves’ orbitopathy Graves’ orbitopathy (GO) is the most frequent extrathyroid complication in Graves’ disease. Natural history, described by Rundle, features an initial inflammatory or active phase in which acute episodes and ...
Daumerie, Chantal +3 more
core +1 more source
Journal of Ophthalmology, Volume 2026, Issue 1, 2026.Objective To evaluate the efficacy and safety of the Deep Cleaning Device for the treatment of blepharitis. Methods This prospective, randomized controlled trial enrolled 51 adult patients with blepharitis, who were randomly allocated to two treatment groups.
Ya Wen +7 more
wiley +1 more source
RNFL Study in Graves Orbitopathy
, 2010 Purpose:to determine changes of retinal nerve fiber layer (RNFL) in a group of patients with serious thyroid-related immune orbitopathy and compare it with a group of patients with moderate Graves orbitopathy.
CAMPANERUT, SARA +4 more
core
Clinical assessment of patients with Graves' orbitopathy
, 2011 Clinical examination is the basis of a good assessment of a patient with Graves' orbitopathy. This study gives recommendations of the European orbitopathy group related to the activity and severity of the disease. The activity of the disease is estimated
Nedeljković-Beleslin Biljana
core +1 more source
Medical Treatment of Graves’ Orbitopathy
Hormone and Metabolic Research, 2015 The medical treatment of Graves' orbitopathy (GO) is usually reserved to moderate to severe disease. Steroids have been widely employed and possess anti-inflammatory activity, but about 20-30% of patients are not responsive and about 20% present with disease recurrence.
Salvi, M., Campi, I.
openaire +2 more sources
The Clinical Characteristics of Thyroid Orbitopathy in Thyroid Dysfunction Patients in Korea
, 2008 PURPOSE: To investigate the clinical manifestation of thyroid orbitopathy among patients with thyroid dysfunction. METHODS: A cross-sectional study was conducted at 24 general hospitals in Korea.
이상열
core +1 more source